Supraventricular tachycardia in an adolescent with attention-deficit/ hyperactivity disorder (ADHD)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 47, Issue 2, 2008, Pages 219-220

  Hammerness, Paul G ^a   Wilens, Timothy E ^a   Berul, Charles I ^b   Elkort, Michael S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; CASE REPORT; CATHETER ABLATION; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; HEART DISEASE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA;

EID: 38549177365     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31815d7485     Document Type: Letter

References (4)

1. Wilens TE, Biederman J, Lerner M, the Concerta Study Group. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. J Clin Psychopharmacol. 2004;24:36-41.
2. Findling RL, Biederman J, Wilens T, et al. Short and long-term cardiovascular effects of mixed amphetamine salts extended release (Adderall XR) in children. J Pediatr. 2005;147:348-354.
3. Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation. 1999;99:979-982.
4. Wilens T, Spencer T, Prince J, et al. Stimulants and sudden death: what is a physician to do? Pediatrics. 2006;118:1215-1219.